SPOTLIGHT -
Kelvin Tsoi, PhD: Combination Therapy, Monotherapy in Alzheimer Disease
After identifying and reviewing 76 randomized trials, combination therapy with memantine and AChEIs is confirmed to have no additional benefits over monotherapy.